Stay updated on Tazemetostat + Pembrolizumab in Urothelial Carcinoma Clinical Trial

Sign up to get notified when there's something new on the Tazemetostat + Pembrolizumab in Urothelial Carcinoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Tazemetostat + Pembrolizumab in Urothelial Carcinoma Clinical Trial page

  1. Check
    2 days ago
    Change Detected
    Summary
    A banner announces updates to NIH websites and says some NIH content may use “Super Intelligence” (SI) in place of “Artificial Intelligence” (AI) during the transition.
    Difference
    1%
    Check dated 2026-10-24T14:46:12.000Z thumbnail image
  2. Check
    9 days ago
    Change Detected
    Summary
    The footer’s site revision changed from v3.7.1 to v3.7.2; the page still displays a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-17T14:39:17.000Z thumbnail image
  3. Check
    16 days ago
    Change Detected
    Summary
    The footer revision label changes from v3.7.0 to v3.7.1 while the page remains a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-10T14:38:53.000Z thumbnail image
  4. Check
    37 days ago
    Change Detected
    Summary
    The study page now shows a 403 Forbidden error, making the record inaccessible. The visible additions include a 403 header and a Home button, signaling an access issue rather than a change to trial data.
    Difference
    21%
    Check dated 2026-09-19T18:44:04.000Z thumbnail image
  5. Check
    57 days ago
    Change Detected
    Summary
    The page was updated to revision v3.6.6, replacing the previous v3.6.5. This appears to be an internal update to the page version and does not modify the study details or visible content.
    Difference
    0.0%
    Check dated 2026-08-29T19:26:26.000Z thumbnail image
  6. Check
    79 days ago
    Change Detected
    Summary
    A newer revision label (v3.6.5) is shown, indicating a site update; the core study information remains unchanged.
    Difference
    0.0%
    Check dated 2026-08-08T10:36:06.000Z thumbnail image

Stay in the know with updates to Tazemetostat + Pembrolizumab in Urothelial Carcinoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Tazemetostat + Pembrolizumab in Urothelial Carcinoma Clinical Trial page.